Compounds > thrombin receptor peptide sfllrnp
Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and linsidomine

thrombin receptor peptide sfllrnp has been researched along with linsidomine in 1 studies

Compound Research Comparison

Studies
(thrombin receptor peptide sfllrnp)		Trials
(thrombin receptor peptide sfllrnp)		Recent Studies (post-2010)
(thrombin receptor peptide sfllrnp)		Studies
(linsidomine)		Trials
(linsidomine)		Recent Studies (post-2010) (linsidomine)
9210291,4413594

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donham, DC; Frossard, M; Homoncik, M; Jilma, B; Keuzer, C; Sorenson, JR1

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and linsidomine

ArticleYear
Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:2

    Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Calmodulin; Cross-Sectional Studies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Flow Cytometry; Humans; In Vitro Techniques; Male; Molsidomine; Nitric Oxide Synthase; omega-N-Methylarginine; P-Selectin; Peptide Fragments; Platelet Aggregation Inhibitors; Salicylates

2003